The short version
- The randomised GlyNAC trial in older adults had 12 people in the treatment arm and 12 on an isonitrogenous alanine placebo, running for 16 weeks.
- Both the 2021 pilot and the 2023 randomised trial come from the same research group at one institution, and no independent replication has been published.
- The 2023 trial reported improvements across glutathione deficiency, oxidative stress, mitochondrial dysfunction, insulin resistance, gait speed, muscle strength and blood pressure, and reported the supplement as safe and well tolerated.
- GlyNAC-supplemented mice lived 24% longer than controls in a study by the same group, which is a rodent lifespan result and not a human one.
- N-acetylcysteine at 20mg/kg/day blunted post-exercise signalling through protein kinase B, mTOR and p70S6K in a crossover trial of ten men, and only the placebo group fully recovered performance.
GlyNAC is not a brand. It is shorthand for glycine plus N-acetylcysteine taken together, on the theory that older adults are short of glutathione — the body's main intracellular antioxidant — and that supplying both of its rate-limiting precursors restores it.
It is a tidy hypothesis with a specific mechanism, and the published results are among the most sweeping in the longevity literature. That combination should make you read more carefully, not less.
What the trials found
The pilot, published in 2021, was a 36-week open-label study in eight older adults and eight young adults. After 24 weeks of GlyNAC, the older group's red blood cell glutathione deficiency corrected, oxidative stress fell, mitochondrial fuel oxidation improved, and the authors also reported improvements in inflammation, endothelial function, insulin resistance, genomic damage, cognition, grip strength, gait speed, six-minute walk and body composition. Twelve weeks after stopping, the benefits declined.
The randomised follow-up, published in 2023, took 24 older adults and randomised twelve to GlyNAC and twelve to an isonitrogenous alanine placebo for 16 weeks, with a further twelve young adults taking GlyNAC for two weeks as a comparison group. The reported conclusion: GlyNAC, and not placebo, improved or corrected glutathione deficiency, oxidative stress, mitochondrial dysfunction, insulin resistance, multiple ageing hallmarks, gait speed, muscle strength, six-minute walk, waist circumference and systolic blood pressure. It was safe and well tolerated.
A mouse study from the same group reported that GlyNAC-supplemented C57BL/6J mice lived 24% longer than controls.
Now read the sample sizes again
Twelve people in the treatment arm. Sixteen weeks. One laboratory.
That is not a criticism of the researchers, who have been consistent, mechanistically careful, and open about their design. It is a statement about what the evidence base can currently support. A single group producing a long list of positive findings across many outcomes in very small samples is the classic setup for effects that shrink or vanish when somebody else tries.
Two further things are worth noticing. First, the outcome list is unusually long — when almost every measured variable improves, the probability that some of them are noise rises with the number measured. Second, there is no independent replication. Not a failed replication, which would be informative. Simply none yet.
We are not saying GlyNAC does not work. We are saying that a supplement sold to you today on this evidence is being sold at pilot stage, and the price rarely reflects that.
The caveat almost nobody prints
N-acetylcysteine is a thiol antioxidant, and there is a specific reason to think twice about taking one around training.
Michailidis and colleagues gave ten men NAC at 20mg per kilogram per day or placebo after 300 eccentric contractions, in a double-blind crossover, with muscle biopsies at four time points over eight days. NAC did attenuate markers of muscle damage and inflammation in the first two days. It also blunted the increase in phosphorylation of protein kinase B, mTOR, p70S6K, ribosomal protein S6 and p38 MAPK at two and eight days after exercise, and reduced myogenic determination factor. The line that matters: performance was completely recovered only in the placebo group.
Those are the signalling pathways through which resistance training tells muscle to adapt. Damping the oxidative signal damped the adaptation.
That trial used a single high dose in a damaging-exercise model and does not automatically generalise to chronic lower-dose GlyNAC in older adults, who may have a genuinely different redox baseline. But it is a real, specific, biologically coherent reason not to assume more antioxidant is better, particularly if the reason you are interested in GlyNAC is to support training.
How this compares to its neighbours
Of everything in the longevity aisle, GlyNAC's human data is more direct than most: real functional endpoints, a real placebo, a real biochemical mechanism confirmed to move. It beats spermidine, whose one well-powered trial came back flat, and it beats senolytics, where the product you can buy is not the one that was tested.
What it does not have is scale or independence. Twenty-four people, one lab, and a hallmarks-of-ageing framing that leans on composite scores rather than outcomes anyone tracks over decades. And the strength and gait improvements, while genuine-looking, are being reported in a field where the same measures are moved reliably and cheaply by resistance training and by improving cardiorespiratory fitness.
What we would actually tell you
We do not sell GlyNAC. If you want to try it, glycine and N-acetylcysteine are both inexpensive as separate ingredients, and there is no reason to pay a premium for the acronym.
Give it a defined window and a concrete measure — gait speed over a marked distance, grip, a timed sit-to-stand — rather than a vague sense of vitality, because a vague sense is exactly what an unblinded expectation manufactures.
Speak to your doctor first if you take nitrates or have asthma, since NAC has interactions worth checking. And if the reason you want it is training adaptation, weigh the thiol antioxidant caveat seriously. Being early on a promising compound is a legitimate choice. Believing you are late is the mistake.
Good questions
Does GlyNAC actually work?
The published results are striking and the evidence base is very small. The randomised trial had twelve people taking GlyNAC for sixteen weeks, and every human study so far comes from one laboratory with no independent replication. That is pilot-stage evidence for a compound often sold at premium prices. It may hold up; nobody has yet checked.
Can I just take glycine and NAC separately?
Yes, and that is what the trials used — the two amino acid compounds dosed together, not a proprietary blend. Both are inexpensive as separate ingredients. There is no evidence that a branded combination outperforms buying them individually, so paying extra for the acronym is paying for packaging.
Is NAC bad for muscle gains?
There is a real reason for caution. In ten men given NAC at 20mg per kilogram daily after damaging exercise, the supplement blunted the anabolic and stress signalling that drives adaptation, and only the placebo group fully recovered performance. That was one high dose in a damage model, not chronic use in older adults, but if training adaptation is your goal it is worth weighing.
Is GlyNAC safe?
It was reported as safe and well tolerated in the sixteen-week randomised trial and the twenty-four-week pilot, but those involved fewer than thirty older adults in total. Longer-term data does not exist. Check with your doctor first if you take nitrates or have asthma, as N-acetylcysteine has known interactions in both situations.
Does GlyNAC reverse aging?
No trial has shown that. The published work reports improvements in oxidative stress markers, mitochondrial measures and composite hallmark scores in small groups over weeks. Hallmark scores are not lifespan, and the 24% longer life came from mice. Treat the reversal language as a summary of biochemistry, not of years.
Is it worth the money?
Only if you understand you are buying at pilot stage, and only after the basics are covered. The functional gains reported — gait speed, grip, walking distance — are the same ones resistance training moves reliably and for free. We do not sell GlyNAC, so there is nothing behind that answer except the sample sizes.
Sources
- Kumar P, Liu C, Hsu JW, et al. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. Clin Transl Med, 2021. View study
- Kumar P, Liu C, Suliburk J, et al. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci, 2023. View study
- Kumar P, Osahon OW, Sekhar RV. GlyNAC (Glycine and N-Acetylcysteine) Supplementation in Mice Increases Length of Life by Correcting Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Abnormalities in Mitophagy and Nutrient Sensing, and Genomic Damage. Nutrients, 2022. View study
- Michailidis Y, Karagounis LG, Terzis G, et al. Thiol-based antioxidant supplementation alters human skeletal muscle signaling and attenuates its inflammatory response and recovery after intense eccentric exercise. Am J Clin Nutr, 2013. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
